In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Diabetogen Biosciences, Inc.

Latest From Diabetogen Biosciences, Inc.

Almirall Goes All In On Generative AI

Dermatology-focused Almirall S.A. is partnering with Microsoft for generative artificial intelligence capabilities. It is the second generative AI-based collaboration announced by Almirall in several months. 

Innovation Market Intelligence

2024 Radar: UK Medtechs Up The Pace On Sustainability And Assess AI Potential

Three UK medtech companies’ views on how their businesses will be influenced by external factors in the coming year.

United Kingdom Medical Device

5-Minute Podcast: An SME's Environmental Sustainability Challenge − Pennine Healthcare

Medtech SME Pennine Healthcare has a range of business challenges to navigate, but compliance with heightened environmental sustainability standards has rapidly risen up its list of priorities.

Sustainability Policy

2024 Radar: UK Medtechs Up The Pace On Sustainability And Assess AI Potential

Three UK medtech companies’ views on how their businesses will be influenced by external factors in the coming year.

United Kingdom Medical Device
See All

Company Information

  • Industry
  • Biotechnology
UsernamePublicRestriction

Register